http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-19990007390-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
filingDate | 1998-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1999-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-19990007390-A |
titleOfInvention | Quinolone Carboxylic Acid Derivatives |
abstract | The present invention relates to a quinolone carboxylic acid derivative having superior and broad antibacterial activity compared to conventional quinolone antibiotics, and more particularly, 7- [8- (alkoxyimino) -2,6-diazaspiro [3.4 A novel quinolonecarboxylic acid derivative represented by the following formula (1) having a derivative of] oct-6-yl] as a substituent, a pharmaceutically acceptable salt thereof, an isomer thereof, and a method for preparing the same.n n n n n n n n n n In the above formula, A is CH, CF, C-Cl, CO-CH 3, or N, Y is hydrogen or amino, R 1 is cyclopropyl or 2,4-difluorophenyl, R 2 is C 1-4 lower alkyl and R 3 is hydrogen or C 1-4 lower alkyl. |
priorityDate | 1997-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 98.